Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.
by Kendall K. Morgan
My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.
Researchers are investigating why certain patients have an exceptional response to a particular drug.
Some cancers that are most commonly diagnosed in older adults are becoming increasingly prevalent in young adults.
An analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19.
Researchers discussed the impact of COVID-19 on minority populations and recent research in the COVID-19 field.
The FDA has expanded the use of the PARP-targeted therapeutic olaparib to include the treatment of certain patients with metastatic prostate cancer.
While melanoma is rarer than other forms of skin cancer, it is more aggressive and more likely to spread to other organs.
Handle With Care
donate to the AACR
The AACR Cancer Progress Report 2019, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.